Christopher R. Fenimore - Aug 28, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role: SVP Finance & CFO
Signature: /s/**Christopher R. Fenimore
Stock symbol: REGN
Transactions as of: Aug 28, 2024
Transactions value $: -$6,846,262
Form type: 4
Date filed: 8/29/2024, 04:27 PM
Previous filing: Feb 12, 2024
Next filing: Dec 10, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REGN	Common Stock	Sale	-$275K	-228	-19.1%	$1,204.79	966	Aug 28, 2024	2021 GRAT	F1
transaction	REGN	Common Stock	Sale	-$923K	-766	-79.3%	$1,205.44	200	Aug 28, 2024	2021 GRAT	F2
transaction	REGN	Common Stock	Sale	-$241K	-200	-100%	$1,206.30	0	Aug 28, 2024	2021 GRAT	F3
transaction	REGN	Common Stock	Sale	-$2.69M	-2.24K	-61.88%	$1,204.71	1.38K	Aug 28, 2024	2022 GRAT	F4
transaction	REGN	Common Stock	Sale	-$1.12M	-928	-67.34%	$1,205.49	450	Aug 28, 2024	2022 GRAT	F5
transaction	REGN	Common Stock	Sale	-$543K	-450	-100%	$1,206.15	0	Aug 28, 2024	2022 GRAT	F6
transaction	REGN	Common Stock	Sale	-$285K	-236	-51.19%	$1,205.67	225	Aug 28, 2024	by Trust for Daugh	F7
transaction	REGN	Common Stock	Sale	-$241K	-200	-88.89%	$1,206.70	25	Aug 28, 2024	by Trust for Daugh	F8
transaction	REGN	Common Stock	Sale	-$283K	-235	-51.09%	$1,205.67	225	Aug 28, 2024	by Trust for Son	F9
transaction	REGN	Common Stock	Sale	-$241K	-200	-88.89%	$1,206.67	25	Aug 28, 2024	by Trust for Son	F10
holding	REGN	Common Stock						15.3K	Aug 28, 2024	Direct
holding	REGN	Common Stock						1.52K	Aug 28, 2024	By 401(k) Plan
holding	REGN	Common Stock						1.9K	Aug 28, 2024	By Trust	F11

Showing 1 to 13 of 13 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents volume-weighted average price of sales of 228 shares of Company stock on August 28, 2024 at prices ranging from $1,204.76 to $1,204.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F2	Represents volume-weighted average price of sales of 766 shares of Company stock on August 28, 2024 at prices ranging from $1,205.02 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F3	Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.09 to $1,206.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F4	Represents volume-weighted average price of sales of 2,237 shares of Company stock on August 28, 2024 at prices ranging from $1,204.00 to $1,204.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F5	Represents volume-weighted average price of sales of 928 shares of Company stock on August 28, 2024 at prices ranging from $1,205.00 to $1,205.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F6	Represents volume-weighted average price of sales of 450 shares of Company stock on August 28, 2024 at prices ranging from $1,206.00 to $1,206.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F7	Represents volume-weighted average price of sales of 236 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F8	Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.66 to $1,206.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F9	Represents volume-weighted average price of sales of 235 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F10	Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.65 to $1,206.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
F11	These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.